Buy Jalyn, Duodart, Urimax-D (Dutasteride and Tamsulosin) to treat BPH in men
Cheap qualitative Dutasteride with Tamsulosin HCl 0.5 mg / 0.4 mg pills online
HOW AND WHERE TO BUY URIMAX-D, DUODART, JALYN (DUTASTERIDE WITH TAMSULOSIN) 0.5 MG / 0.4 MG TABLETS OR CAPSULES ONLINE:
DUODART (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE): ADVERSE REACTIONS, SIDE EFFECTS
There have been no clinical trials conducted with Duodart (Dutasteride with Tamsulosin); however, co-administration information for Years 1 and 2 is available from the CombAT (Combination of Avodart and Tamsulosin) study, a comparison of dutasteride 0.5 mg and tamsulosin 0.4 mg once daily for four years as co-administration or as monotherapy.
Information on the adverse event profiles of the individual components (dutasteride and tamsulosin) is also provided.
Dutasteride and Tamsulosin (Duodart) Co-administration
Clinical Trial Data
Year 2 data from the CombAT study have shown that the incidence of any investigatorjudged drug-related adverse event during the first and second years of treatment respectively was 22% and 5% for dutasteride + tamsulosin co-administration therapy, 14% and 5% for dutasteride monotherapy and 13% and 4% for tamsulosin monotherapy. The higher incidence of adverse events in the co-administration therapy group in the first year of treatment was due to a higher incidence of reproductive disorders, specifically ejaculation disorders, observed in this group.
The following investigator-judged drug-related adverse events (with an incidence of greater than or equal to 1%) have been reported during Years 1 and 2 of the CombAT study: altered
(decreased) libido, impotence, ejaculation disorders, breast disorders, dizziness.
Clinical Trial Data
In three phase III placebo controlled studies of dutasteride treatment (n=2167) compared to placebo (n=2158), investigator-judged drug-related adverse events after one and two
years of therapy were similar in type and frequency to those observed in the dutasteride monotherapy arm of the CombAT study (see table above).
No change in the adverse event profile was apparent over a further 2 years in an open-label extension phase of these studies.
Post Marketing Data
Adverse drug reactions are listed below by system organ class and frequency. Frequencies are defined as: very common ( >= 1/10), common ( >= 1/100 and < 1/10), uncommon ( >= 1/1000 and < 1/100), rare ( >= 1/10,000 and < 1/1000) and very rare ( < 1/10,000) including isolated reports. Frequency categories determined from post-marketing data refer to reporting rate rather than true frequency.
Immune system disorders
Very rare: including rash, allergic reactions, pruritus, localised oedema, urticaria, angioedema.
Skin and subcutaneous tissue disorders
Rare: alopecia (primarily body hair loss), hypertrichosis.
Clinical Trial Data and Post marketing Data
Rarely, tamsulosin, like other alpha1-antagonists, has been associated with priapism (persistent painful penile erection unrelated to sexual activity). Patients should be informed that this reaction is extremely rare, but if not brought to immediate medical attention, can lead to permanent erectile dysfunction.
Patients should also be advised on the potential for abnormal ejaculation, such as retrograde ejaculation, to occur upon commencement of tamsulosin treatment.
GlaxoSmithKline does not hold the safety database for any single ingredient tamsulosin product; therefore the adverse reactions and frequency categories below are based on information available in the public domain. In the table below, common and uncommon reactions are consistent with those identified in a clinical trial setting and the frequency categories generally reflect incidence over placebo. Rare and very rare reactions are consistent with those identified from post marketing reports and the frequency categories reflect reporting rates.
Cardiac disorders: uncommon: palpitations
Gastrointestinal disorders: uncommon: diarrhoea, vomiting, constipation
General disorders and administration site disorders: uncommon: asthenia
Nervous system disorders: common: dizziness; rare: syncope
Reproductive system and breast disorders: uncommon: abnormal ejaculation; uncommon: priapism
Respiratory, thoracic and mediastinal disorders: uncommon: rhinitis
Immune system disorders: uncommon: pruritis, rash, urticaria; rare: angioedema
Vascular disorders: uncommon: postural hypotension
During post marketing surveillance, reports of Intraoperative Floppy Iris Syndrome (IFIS), a variant of small pupil syndrome, during cataract surgery have been associated with alpha-1 adrenergic blocker therapy; including tamsulosin. Infrequent reports of skin desquamation have also been received.
Duodart (Dutasteride, Tamsulosin) related pharmaceutical drugs and medications
|Trade name of the drug
||Pharmaceutical forms and doses
|Minipress adverse reactions, side effects - Prazosin Hydrochloride
||Capsules; Oral; Prazosin Hydrochloride 1 mg
|Cialis adverse reactions, side effects - Tadalafil
||Tablets, Film-Coated; Oral; Tadalafil 2.5 mgTablets, Film-Coated; Oral; Tadalafil 20 mg
Buy Duodart (Dutasteride, Tamsulosin HCl) Online
Duodart prescribing information
Copyright © Buy Jalyn, Duodart, Urimax-D (Dutasteride with Tamsulosin) Online